Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
Clinical and Molecular Hepatology · 2023
DOI: 10.3350/cmh.2023.0250 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical and Molecular Hepatology, 2023. Verfasst von Eugene Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Sarcopenia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.
Förderung
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Han, E., & Lee, Y. H. (2023). Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2023.0250
Vancouver
Han E, Lee YH. Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?. Clinical and Molecular Hepatology. 2023. doi:10.3350/cmh.2023.0250
BibTeX
@article{Han2023,
author = {Han, Eugene and Lee, Yong-Ho},
title = {Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?},
journal = {Clinical and Molecular Hepatology},
year = {2023},
doi = {10.3350/cmh.2023.0250}
}
EUVIMED